The Effect of pH on the In Vitro Colony Forming Ability of Transitional Cell Carcinoma Cells Treated with Various Chemotherapeutic Agents: Implications for In Vivo Therapy
- 1 February 1992
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 147 (2) , 511-513
- https://doi.org/10.1016/s0022-5347(17)37290-7
Abstract
Extracellular pH may affect the sensitivity of cancer cells to chemotherapy agents. In an attempt to maximize the conditions for chemotherapy treatment of transitional cell carcinoma we tested the effect of pH on sensitivity of MGH-U3 transitional cell carcinoma cell line to thiotepa, doxorubicin, and mitomycin c in vitro. The toxicity of each agent tested varied with pH. There was no variation in cell growth in response to pH alone. The cytotoxic activity of thiotepa was markedly enhanced when cells were treated with a diluent pH of 5.5. Significant differences were also observed after treatment with doxorubicin and mitomycin c with a diluent pH of 7.0. This in vitro assay may be useful for clinical application of pH modulation during intravesical chemotherapy.Keywords
This publication has 11 references indexed in Scilit:
- Selecting initial therapy for bladder cancerCancer, 1987
- Bacillus Calmette-Guerin for Treatment of Superficial Transitional Cell Carcinoma of the Bladder in Patients who have failed Thiotepa and/or Mitomycin CJournal of Urology, 1987
- Intravesical chemotherapy: Studies on the relationship between ph and cytotoxicityCancer, 1986
- Absorption of anticancer drugs through bladder epitheliumUrology, 1986
- UROTHELIAL DYSPLASIA CONCOMITANT WITH BLADDER TUMOURS AS A DETERMINANT FACTOR FOR FUTURE NEW OCCURRENCESThe Lancet, 1983
- Optimising mitomycin C activity during intravesical instillationUrological Research, 1983
- Intravesical Chemotherapy of Superficial Bladder CancerPublished by Springer Nature ,1983
- The Use of Intravesical Thio-Tepa in the Management of Non-invasive Carcinoma of the BladderJournal of Urology, 1981
- „NORMAL” urothelium in patients with bladder cancer.A preliminary report from the national bladder cancer collaborative group aCancer, 1979
- Clinical studies on triethylenephosphoramide and diethylenephosphoramide, compounds with nitrogen-mustard-like activityCancer, 1953